ArticleAmerican journal of cancer research2024

Adjuvant osimertinib therapy guided by ctDNA-assessed MRD in resected EGFR-mutated stage IA-IIA non-small-cell lung cancer: a randomized clinical trial study protocol.

Kun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.